Insmed
INSM
#759
Rank
โ‚น2.868 T
Marketcap
โ‚น13,307
Share price
-0.85%
Change (1 day)
99.64%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -โ‚น95.42 Billion

According to Insmed's latest financial reports the company's current earnings are โ‚น0.44 Billion. In 2024 the company made an earning of -โ‚น77.39 Billion a decrease over its 2023 earnings that were of -โ‚น62.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น95.42 Billion23.31%
2024 -โ‚น77.39 Billion23.71%
2023 -โ‚น62.55 Billion45.77%
2022 -โ‚น42.92 Billion15.83%
2021 -โ‚น37.05 Billion50.19%
2020 -โ‚น24.67 Billion16.4%
2019 -โ‚น21.2 Billion-23.9%
2018 -โ‚น27.85 Billion59.35%
2017 -โ‚น17.48 Billion8.52%
2016 -โ‚น16.11 Billion47.25%
2015 -โ‚น10.94 Billion34.53%
2014 -โ‚น8.13 Billion58.83%
2013 -โ‚น5.12 Billion35.14%
2012 -โ‚น3.79 Billion-31.92%
2011 -โ‚น5.57 Billion854.92%
2010 -โ‚น0.59 Billion-105.22%
2009 โ‚น11.15 B-905.06%
2008 -โ‚น1.39 Billion-27.31%
2007 -โ‚น1.91 Billion-62.41%
2006 -โ‚น5.08 Billion98.19%
2005 -โ‚น2.56 Billion0.03%
2004 -โ‚น2.56 Billion159.07%
2003 -โ‚น0.99 Billion-69.31%
2002 -โ‚น3.22 Billion
2000 -โ‚น2.91 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.524 T-1,585.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚น921.88 B-997.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น416.04 B-505.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น23.52 Billion-77.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.17 Billion-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚น0.41 B-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA